Status:
COMPLETED
Vancomycin Dosage Strategy Based on a Trough Concentration Model
Lead Sponsor:
Peking University Third Hospital
Conditions:
Pneumonia, Staphylococcal
Eligibility:
All Genders
60+ years
Phase:
PHASE4
Brief Summary
Study design: Allocation: Randomized Endpoint classification: Efficacy study Masking: Open label Primary purpose: Treatment Primary endpoint: Incidence of reaching the target serum trough concentrati...
Detailed Description
This is a prospective randomized control trial. There are two groups, study group and control group. Patients of study group accepted vancomycin strategies decided by a serum trough concentration mode...
Eligibility Criteria
Inclusion
- Patients with doubted or diagnosed Methicillin-resistant Staphylococcus aureus severe pneumonia, and need vancomycin treatment.
- Sixty years and older.
Exclusion
- younger than 60 years old
- Accepted blood purification therapy
- Pregnancy
- Positive HIV antibody titre
- Had known or suspected tuberculosis or other infections caused by fungi at baseline.
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT04088305
Start Date
October 1 2019
End Date
June 30 2022
Last Update
August 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University Third Hospita
Beijing, Beijing Municipality, China, 100191